Baird Maintains Outperform on AdaptHealth, Raises Price Target to $16
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.